Bruton Tyrosine Kinase Inhibitor ONO/GS-4059: From Bench to Bedside

Oncotarget - United States
doi 10.18632/oncotarget.12786
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Homogeneous BTK Occupancy Assay for Pharmacodynamic Assessment of Tirabrutinib (GS-4059/ONO-4059) Target Engagement

SLAS Discovery
BiochemistryBiotechnologyAnalytical ChemistryMolecular Medicine
2018English

Ono-4059 (Gs-4059), a Next Generation BTK Inhibitor, Monotherapy in Patients With B-Cell Malignancies in the Japanese Phase 1, Dose-Escalation Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

From Bench to Bedside

Circulation Journal
MedicineCardiovascular MedicineCardiology
2008English

Ebola From Bedside to Bench

Cell
BiochemistryGeneticsMolecular Biology
2019English

CXCR2: From Bench to Bedside

Frontiers in Immunology
AllergyImmunology
2012English

Sepsis: From Bench to Bedside

Clinics
Medicine
2008English

Inflammatory Disease: From Bench to Bedside

Autoimmunity
AllergyImmunology
2010English

Wireless Neuromodulation: From Bench to Bedside

2019English

Immunotherapy in ALL: From Bench to Bedside

Egyptian Journal of Hematology and Bone Marrow Transplantation
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy